Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes

Area of Science:

• Immunology
• Infectious Diseases
• Genomics

Background:

• CD8(+) T cells restricted by human leucocyte antigen (HLA) class I are crucial for protective immunity against tuberculosis.
• However, limited Mycobacterium tuberculosis-specific T cell epitopes have been identified.
• Understanding these epitopes is key to developing effective tuberculosis vaccines and therapies.

Purpose of the Study:

• To identify novel HLA-B*3501-restricted T cell epitopes from Mycobacterium tuberculosis using a genome-wide screening approach.
• To assess the immunogenicity of these candidate epitopes in naturally infected individuals.
• To explore the potential of these epitopes in understanding T cell responses against tuberculosis.

Main Methods:

• A genome-wide screen of Mycobacterium tuberculosis was performed to predict potential HLA-B*3501 T cell epitopes.
• 479 epitopes were predicted, and the top 13 were synthesized.
• Lymphocytes from healthy, naturally exposed HLA-B*3501 individuals were stimulated using cultured and ex vivo enzyme-linked immunospot (ELISPOT) assays for interferon (IFN)-gamma.

Main Results:

• All 13 synthesized peptides elicited an IFN-gamma response, with significant inter-individual variation.
• CD8(+) T cell lines were successfully expanded for three of the peptides.
• Four peptides were recognized permissively by the HLA-B7 supertype family, indicating broader applicability.

Conclusions:

• A genome-wide screening approach is feasible for identifying novel mycobacterial antigens involved in natural anti-tuberculosis immunity.
• The identified epitopes demonstrate the potential for CD8(+) T cell responses against a wide range of M. tuberculosis antigens.
• Further research is warranted to fully elucidate the role of these epitopes in protective immunity against tuberculosis.